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Abstract
Background: Observational studies show moderate alcohol use negatively associated with ischemic heart disease (IHD) and
cardiovascular disease (CVD). However, healthier attributes among moderate users compared to never users may confound
the apparent association. A potentially less biased way to examine the association is Mendelian randomization, using
alcohol metabolizing genes which influence alcohol use.
Methods: We used instrumental variable analysis with aldehyde dehydrogenase 2 (ALDH2) genotypes (AA/GA/GG) as
instrumental variables for alcohol use to examine the association of alcohol use (10 g ethanol/day) with CVD risk factors
(blood pressure, lipids and glucose) and morbidity (self-reported IHD and CVD) among men in the Guangzhou Biobank
Cohort Study.
Results: ALDH2 genotypes were a credible instrument for alcohol use (F-statistic 74.6). Alcohol was positively associated
with HDL-cholesterol (0.05 mmol/L per alcohol unit, 95% confidence interval (CI) 0.02 to 0.08) and diastolic blood pressure
(1.15 mmHg, 95% CI 0.23 to 2.07) but not with systolic blood pressure (1.00 mmHg, 95% CI -0.74 to 2.74), LDL-cholesterol
(0.03 mmol/L, 95% CI -0.03 to 0.08), log transformed triglycerides (0.03 mmol/L, 95% CI -0.01 to 0.08) or log transformed
fasting glucose (0.01 mmol/L, 95% CI -0.006 to 0.03), self-reported CVD (odds ratio (OR) 0.98, 95% CI 0.76 to 1.27) or selfreported IHD (OR 1.10, 95% CI 0.83 to 1.45).
Conclusion: Low to moderate alcohol use among men had the expected effects on most CVD risk factors but not fasting
glucose. Larger studies are needed to confirm the null associations with IHD, CVD and fasting glucose.
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from the majority of the global population outside western settings
[6–8] where moderate alcohol use is less commonly used as a
social lubricant.
Evidence from randomized controlled trials (RCTs) suggests
that alcohol monotonically increases blood pressure [9,10], high
density lipoprotein (HDL)-cholesterol [11] and triglycerides [11],
whilst the evidence concerning diabetes and glucose metabolism is
more limited [12,13]. There have been no large-scale RCTs of
moderate alcohol use and cardiovascular disease most likely due to
ethical and practical issues. A Mendelian randomization study
provides an alternative approach to establish the causal role of
moderate alcohol use in a suitable population where a genetic
variant affects alcohol metabolism and thereby alcohol use.
Genetic variants in the aldehyde dehydrogenase 2 (ALDH2) gene
do affect alcohol metabolism [14] and have been proposed as

Introduction
In observational studies alcohol usually has a U or J shaped
association with health, such that moderate alcohol use (1–2 drinks
per day) is negatively associated with ischemic heart disease (IHD)
[1] ischemic stroke [2] and diabetes [3]. Correspondingly, some
public health advice implies that moderate alcohol use is protective
against cardiovascular disease (CVD) and diabetes [4]. However,
observational studies are vulnerable to biases from residual
confounding, due to unmeasured systemic differences between
moderate alcohol and other alcohol users [5], from overadjustment due to an imperfect understanding of the underlying
causal pathways and from reverse causality, thus such studies may
not provide a sound basis for causal inference. Notably, the
benefits of moderate alcohol use are not always evident in studies
PLOS ONE | www.plosone.org
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immediate life-threatening risk, such as chemotherapy or radiotherapy for cancer, or dialysis for renal failure. Participants in
GBCS are ethnic Chinese largely from southern China. Participants underwent a detailed interview and physical examination at
baseline recruitment, including medical history and report of
doctor diagnosed conditions. Participants were asked about doctor
diagnosed CVD, and if applicable the type of CVD, such as IHD
or stroke. The methods of measurement have previously been
reported [22]. Alcohol use was recorded in terms of frequency,
type of beverage and usual amount per occasion. We recorded
seated blood pressure as the average of the last two or three
measurements, using the Omron 705CP sphygmomanometer
(Omron Corp., Kyoto, Japan). Fasting low density lipoprotein
(LDL)-cholesterol, high density lipoprotein (HDL)-cholesterol,
triglycerides, and glucose were determined with a Shimadzu CL8000 clinical chemical analyzer (Shimadzu Corp, Kyoto, Japan) in
the hospital laboratory.

suitable predictors of alcohol use for use in Mendelian randomization studies [15]. Mendelian randomization studies can be
thought of in three ways. First, the genotypes can serve as proxies
of the exposure [15], which is particularly useful if the relevant
exposure has not been or cannot be measured. Second, Mendelian
randomization can be thought of as triangulation of genotype,
exposure and outcome, akin to mediation, which is an intuitive
way of thinking of instrumental variable analysis. Third, Mendelian randomization can be thought of as instrumental variable
analysis with genetic instruments, which was used in this study
[16,17], because instrumental variable analysis is a well-established
statistical technique with known statistical assumptions and
properties. ALDH2 alleles are randomly allocated to at conception.
People with inactive ALDH2 alleles flush and feel discomfort
following alcohol use because of acetaldehyde exposure [18].
Genetically determined alcohol use resembles random allocation
in RCTs, and provides a potentially less biased way to assess the
effect of moderate alcohol use on health [15]. People, with inactive
ALDH2 alleles, and correspondingly lower alcohol consumption,
have been observed to have lower blood pressure [19] and lower
HDL-cholesterol [20], consistent with evidence from RCTs.
However these studies lacked information on alcohol use and
used ALDH2 genotypes as proxies of alcohol consumption, rather
than using instrumental variable analysis to estimate the effect of
alcohol use on CVD risk factors.
Southern Chinese men are uniquely suitable for a Mendelian
randomization study of alcohol use with ALDH2 genotype as a
genetic instrument. Inactive alleles of ALDH2 are common in East
Asia. In our study of Southern Chinese ALDH2 alleles are
consistent with Hardy Weinberg equilibrium as required for
Mendelian randomization [21]. ALDH2 was also strongly associated with alcohol use among men but not associated with potential
confounders [21]. We used Mendelian randomization to assess
whether moderate alcohol use was protective against self-reported
CVD, self-reported IHD or major CVD risk factors among men
from the Guangzhou Biobank Cohort Study. We also assessed the
same associations using multivariable regression adjusted for
confounders in an observational study design for comparison.

DNA extraction and SNP analysis
As previously described [21], biological samples for DNA
extraction used in the present study were obtained in GBCS phase
3 at recruitment and in phases 1 and 2 at follow-up. Of the 8,450
men in all three GBCS phases, 5,606 had bio-materials suitable for
DNA extraction. DNA was extracted at Guangzhou No. 12
Hospital either from fresh blood using a standard phenolchloroform extraction procedure and stored at 280uC or from
blood or buffy coat previously stored at 280uC using a standard
magnetic bead extraction procedure. There were 4,987 men with
viable DNA for genotyping. Genotyping of SNP rs671 to identify
ALDH2 genotypes (AA, GA or GG) was performed using the
MassARRAY system (Sequenom, San Diego, CA, USA) and the
iPLEX assay at a commercial company (Beijing CapitalBio
Corporation, Beijing, China).

Alcohol use
The main exposure was continuous alcohol units (10 gram (g)
ethanol per day) based on total alcohol consumption obtained
from the frequency, quantity and type recorded at recruitment
[21]. Specifically, we asked the participants how often they drank
alcohol (once or twice per year, once every couple of months,
,1 day/ week, 1–2 days/week, 3–4 days/week, 5–6 days/week,
daily or almost every day), the type of alcohol usually consumed,
and how much of each type of alcohol (beer, western table wine,
spirits, Chinese rice wine or Chinese rice wine (high strength))
usually consumed per occasion, from which we calculated units
per day. Infeasible amounts (.30 alcohol units per day) were
excluded [21]. Former alcohol users were included as non-drinkers
because former alcohol users may have abstained from alcohol
because of poor health unrelated to former alcohol use; excluding
them could create a bias. Many former users reported previously
infrequent alcohol use, i.e., once or twice a year.

Methods
Ethics statement
The Guangzhou Medical Ethics Committee of the Chinese
Medical Association approved the study and all participants gave
written, informed consent before participation.

Participants
The Guangzhou Biobank Cohort Study (GBCS) is a collaboration between the Guangzhou No.12 Hospital and the Universities of Hong Kong and Birmingham [22]. Recruitment of
participants draws from ‘‘The Guangzhou Health and Happiness
Association for the Respectable Elders (GHHARE)’’, a community
social and welfare association unofficially aligned with the
municipal government where membership is open to anyone aged
50 years or older for a monthly, nominal fee of 4 Yuan (50 US
cents). There were three recruitment phases. Recruitment for
phase 1 took place from September 2003 to November 2004, for
phase 2 from April 2005 to May 2006, and for phase 3 from
September 2006 to January 2008. Follow-up of the participants
started in 2008. Approximately 7% of permanent Guangzhou
residents aged 50 years or more are members of GHHARE, of
whom 33% enrolled for phases 1, 2 or 3 recruitment and were
included if they were capable of consenting, ambulatory, and not
receiving treatment modalities that, if omitted, may result in
PLOS ONE | www.plosone.org

Outcomes
The outcomes were doctor diagnosed self-reported CVD, which
included IHD, stroke/transient ischemic attack, angina, myocardial infarction, peripheral vascular disease, valvular heart disease
and rheumatic heart disease, self-reported IHD, which included
IHD, angina and myocardial infarction, and biological CVD risk
factors, i.e., systolic blood pressure, diastolic blood pressure, HDLcholesterol, LDL-cholesterol and fasting plasma glucose, reflecting
biological risk factors in the Framingham equation. We also
included a related risk factor, triglycerides, because alcohol use has
been positively associated with triglycerides in RCTs [11]. Since
2
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triglycerides and fasting glucose were not normally distributed,
they were log transformed.

Results
Of the 4,987 men with viable DNA, 4,867 had complete
information on ALDH2 genotypes, alcohol use and at least one
outcome. Table 1 shows that men with two active ALDH2 alleles
on average consumed ten times as much alcohol per day (0.9 units)
as men with two inactive alleles (0.09 units). Fifty one percent
(51%) of men were never users. Among current users, the mean
alcohol units consumed was 1.30 (standard deviation 2.88) while
the main alcohol beverage type used was Chinese rice wine (64%).
Relatively few men reported IHD (4.8%) or CVD (6.4%)
consistent with mortality from these causes in China [24]. ALDH2
satisfies the assumptions for being a credible instrument for alcohol
use, including little direct association with the outcomes considered [25], and little association with potential confounders, such as
age, socioeconomic positions and lifestyle (Table 1).
The F-statistic from the first stage of the instrumental variable
analysis was 74.6 (r2 = 0.03), suggesting that weak instrument bias
was unlikely. There was no evidence that the association of
ALDH2 genotypes with alcohol units varied with any of the
outcomes considered. Table 2 shows that in the Mendelian
randomization analysis alcohol was positively associated with
diastolic blood pressure, and HDL-cholesterol. Alcohol was not
associated with systolic blood pressure, LDL-cholesterol, log
transformed triglycerides, log transformed fasting plasma glucose,
self-reported IHD or self-reported CVD.
Most of the observational estimates from multivariable regression were in the same direction as, but smaller than, the
Mendelian randomization estimates. Alcohol was also positively
associated with systolic blood pressure, LDL-cholesterol, and
fasting glucose, but was not associated with self-reported CVD or
self-reported IHD. Associations were similar when former users
were excluded (Table 3) although estimates were larger when
heavy users were excluded (Table 4). Table 5 shows analysis
stratified by age, because genetic associations may be less evident
at older ages when aging and ill-health may have a greater impact
on CVD and its risk factors. The effects of alcohol were more
evident among the younger men.

Statistical analysis
We used analysis of variance (ANOVA) to assess the associations of ALDH2 genotypes with alcohol consumption, blood
pressure and body mass index. We used chi-square tests to assess
whether ALDH2 genotypes were associated with potential
confounders, such as socioeconomic position, lifestyle, and
medication use. We used instrumental variable analysis (2 stage
least squares (2SLS)) with ALDH2 genotype categories as an
instrumental variable, because there was a non-linear association
with alcohol consumption, to obtain estimates of alcohol use on
CVD risk factors, from which we reported b coefficients with 95%
confidence intervals. Such b coefficients represent the effect of one
unit of alcohol on the CVD risk factor. This instrumental variable
analysis obtains the effect of alcohol use on each CVD risk factor
from the association of ALDH2 with the CVD risk factor divided
by the association of ALDH2 with alcohol use, i.e., by using the
relations between genotype, alcohol use and CVD risk factors. For
CVD morbidity, we used instrumental variable probit regression
analysis to obtain the probit coefficient, which we multiplied by 1.6
to obtain the approximate logarithm of the odds ratio [23]. We did
not adjust for confounders in 2SLS or the instrumental variable
probit regression because ALDH2 genotypes randomly allocated at
conception cannot be confounded by age or subsequent socioeconomic position, lifestyle or medication use. Figure 1 depicts the
directed acyclic graph for the Mendelian randomization analyses,
i.e., instrumental variable analysis with genetic instruments, used
in this study.
For comparison, we also present the adjusted associations of
alcohol units with the outcomes under multivariable regression
models in an observational design. We adjusted these multivariable regression models for age, education, physical activity,
smoking status and additionally adjusted analysis of CVD risk
factors for use of appropriate medication.

Sensitivity analyses

Discussion

We repeated the analysis excluding former users in a sensitivity
analysis. Instrumental variable analysis assumes linear association
between alcohol and the CVD. To account for any potential U
shaped relation of alcohol use with CVD, we also repeated the
analysis excluding heavy users (weekly drinking .210 g ethanol/
week) because alcohol use below this level is usually more
monotonic, and so can be modeled as linear.
All statistical analyses were conducted using Stata version 10.1
(StataCorp LP, College Station, TX).

Using a Mendelian randomization design, which utilizes genes
randomly allocated at conception and is similar to the random
allocation process of an RCT [16], in a suitable low to moderate
drinking population of Southern Chinese men, we found low to
moderate alcohol use led to higher diastolic blood pressure, and
HDL-cholesterol, with no protective effect on fasting glucose, selfreported CVD or self-reported IHD. Our results are consistent
with experimental and non-observational evidence showing that
alcohol monotonically increases blood pressure [10,19] and HDLcholesterol [11] with no protective effect on glucose metabolism
[26], although previous studies on glucose metabolism were not
powered to detect a small effect [13]. Our study adds by
confirming these findings in the first comprehensive Mendelian
randomization analysis of the causal effects of moderate alcohol
use on CVD, IHD and CVD risk factors. It also adds by showing,
for the first time, that moderate alcohol use might not have a
protective effect on IHD or CVD morbidity although larger
studies are required to confirm these preliminary null findings.
A Mendelian randomization study design may provide a better
means of generating an unbiased estimate, given systematic
differences among alcohol users. However, limitations of this
study remain. First, the effects of alcohol could vary by ALDH2
genotype due to varying acetaldehyde exposure. However animal
studies suggest acetaldehyde causes cardiovascular harm [27],

Figure 1. Directed acyclic graph showing the framework of
Mendelian randomization analyses in this study.
doi:10.1371/journal.pone.0068054.g001
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Table 1. Alcohol consumption and socio-demographic characteristics by ALDH2 genotype among men from the Guangzhou
Biobank Cohort Study (2003–8).

ALDH2 genotype (from rs671)
Two inactive alleles (AA)

One inactive allele (AG/GA)

No inactive alleles (GG)

Alcohol units (10g

n

416

2,023

2,428

ethanol) per day

mean (SD)

0.09 (0.79)

0.24 (1.22)

0.90 (2.52)

Age group (%) years

n, years

417

2,053

2,457

50–54

11.0

10.0

9.2

55–59

20.9

20.9

21.2

60–64

25.9

23.9

26.3

65–69

19.7

23.8

23.4

70–74

16.3

15.7

14.6

75–79

5.5

4.2

3.7

80+

0.7

1.5

1.4

n

417

2,051

2,455

Less than primary

2.6

2.3

2.3

Primary

24.7

27.3

26.2

Junior middle

29.0

30.3

31.1

Senior middle

27.1

25.1

23.5

Junior college

10.3

8.5

9.2

Education (%)

Smoking status (%)

College

6.2

6.5

7.7

n

416

2,045

2,444

Never

41.1

40.4

40.1

Former

29.3

27.7

27.8

1P value

,0.001

0.41

0.63

0.88

Current

29.6

31.9

32.2

Physical activity

n

417

2,053

2,457

(IPAQ) (%)

Inactive

9.1

8.5

8.1

Minimally active

36.9

38.8

41.6

{HEPA active

54.0

52.7

50.3

n

416

2,045

2,451

drugs (%)

Current user

19.5

18.7

20.2

Lipid modifying

n

417

2,052

2,453

drugs (%)

Current user

5.5

5.4

6.3

0.44

drugs (%)

Current user

6.2

6.2

6.6

0.87

Systolic blood

n

416

2,046

2,449

pressure (mmHg)

mean (SD)

131.2 (19.3)

132.7 (21.1)

133.0 (21.7)

Antihypertensive

Diastolic blood

n

415

2,046

2,446

pressure (mmHg)

mean (SD)

75.3 (10.4)

75.8 (10.9)

76.5 (11.4)

Body Mass

n

416

2,048

2,448

Index (kg/m2)

mean (SD)

23.5 (3.0)

23.5 (3.1)

23.5 (3.2)

0.23

0.49

0.31

0.05

0.84

1

P-value from ANOVA for continuous variables and from a x2 test for categorical variables, 2 sided.
HEPA: health-enhancing physical activity (i.e., vigorous activity at least 3 days a week achieving at least 1,500 metabolic equivalent (MET) minutes per week or activity
on 7 days of the week, achieving at least 3,000 MET minutes per week; IPAQ: International Physical Activity Questionnaire.
doi:10.1371/journal.pone.0068054.t001

{

extrapolated. A meta analysis of observational studies on alcohol
use and cardiovascular outcomes suggest benefits of alcohol use
was observed within this range [1]. Fourth, Mendelian randomization studies require large sample sizes for adequate power.
Power calculation for Mendelian randomization analyses is not
readily available. In the current Mendelian randomization analysis
of ,4,500 men, the r2 (squared correlation) for ALDH2 genotypes
with alcohol units was 0.03. Based on a recent simulation study,
our analysis would be powered to detect effect sizes of at least 0.3

which, if anything, would bias towards a protective effect of active
ALDH2 alleles and hence of alcohol. Second, Mendelian
randomization studies in western populations, where beneficial
effects of moderate alcohol use have most consistently been
observed, might be most convincing. However, Caucasians lack
ALDH2 (rs671) polymorphisms and such studies would need to use
ADH polymorphisms which have weaker associations with alcohol
use in Chinese [28]. Third, the range of alcohol use was mainly
low to moderate, beyond which our findings should not be

PLOS ONE | www.plosone.org
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4,864

0.99

0.94 to 1.05

0.77

standard deviations [29], and analyses for CVD risk factors should
be adequately powered. On the other hand, given the low
prevalence of self-reported CVD and IHD in this study, the
relevant analyses were likely to be underpowered and hence we
only considered these analyses as preliminary. These analyses
should be replicated in future studies with larger sample size. Fifth,
this is not a population representative study, however, disease
prevalence is similar to that in a representative urban Chinese
population [22]. The generalizability of this study will be limited if
amongst the men excluded from this study the effect of genetically
determined alcohol use on CVD and its risk factors differed from
that in the men included, which is unlikely. We did not have
suitable bio-materials for all men from phases 1 and 2. However,
ALDH2 genotypes were not associated with recruitment phase.
Sixth, grape wine was rarely consumed (,10% of all current
alcohol users) but the apparent benefits of alcohol appear to be
independent of beverage types, where the rise in HDL-cholesterol
is similar across beverage types [30]. Although the additional
benefits from wine consumption could be due to resveratrol, or to
confounding by socioeconomic position biasing the estimates from
null [31], wine use is rare in Southern China, so our study is
particularly suitable for establishing the effects of alcohol use.
Seventh, we do not yet have prospective CVD events in this study.
However, we used self-reported CVD and self-reported IHD,
which have previously been shown to be associated with the
metabolic syndrome in this study, indicating some validity of these
self reports [32]. However, misclassification of CVD events arising
from self-reports may have made it more difficult to detect any
association resulting in the observed null associations. Eighth,
Mendelian randomization studies assess the causal effects of
exposure on outcome, Mendelian randomization studies do not
address exactly how any causal effect is mediated. For example our
null association of alcohol use with CVD is consistent with positive
effects of alcohol on blood pressure being balanced out by positive
effects on HDL, but could have occurred by other mechanisms,
which is of etiological relevance and needs to be assessed.
However, from a public health perspective the key question is
the effect of alcohol regardless of how it is mediated. Ninth,
Mendelian randomization studies require no direct association of
the instrument with confounders or the outcomes, as well as
homogenous associations and lack of population stratification [33].
We found no evidence of direct associations of the instrument with
confounders in our previous Mendelian randomization study [21]
or any direct genetic associations with the outcomes among a
random sample of women who were mostly never/occasional
users (data not shown). Our study was drawn from permanent
residents of Guangzhou who are ethnically homogeneous.
Nevertheless, as with any study, we cannot rule out all possible
biases. In addition, Mendelian randomization requires additional
assumptions and some of them are not always verifiable [33].
Tenth, we did not test for a curvilinear association of alcohol use
with CVD or its risk factors as instrumental variable analysis
assumes linearity between alcohol and the outcomes. On the other
hand, in our setting alcohol use is generally low and in the range
where the observed associations of alcohol use with CVD and its
risk factors are usually linear. However, we presented an
additional analysis excluding heavy users (Table 4), which gave a
similar interpretation. In additional, although observational
associations may be curvilinear, causal effects are more often
linear, such that a dose-response relation is one of the Bradford
Hill criteria for causality. Eleventh, genetic associations with
health may be less evident at older ages, potentially creating a bias
towards the null. In age-stratified analysis the effects of alcohol on

"

1

{

adjusted for age, education, physical activity, smoking and use of appropriate medication (CVD risk factors only).
per alcohol unit change (10 grams ethanol/day).
Odds ratio is approximated by the antilogarithm of (1.66 probit coefficient).
doi:10.1371/journal.pone.0068054.t002

0.50
0.83 to 1.45
1.10
4,867
Self-reported IHD

p value

0.82
0.95 to 1.04

95% CI
Odds ratio

0.99
4,864

n
p value

0.90
0.76 to 1.27

95% CI
Odds ratio

0.98

n

4,867
Self-reported CVD

,0.001
0.002 to 0.007
0.005
4,830
0.23
0.01
4,837
Log transformed fasting glucose (mmol/L)

0.03
4,838

20.006 to 0.03

,0.001

0.05
0.00 to 0.02
0.009
4,830
0.31

0.12

LDL-cholesterol (mmol/L)

20.03 to 0.08

0.008 to 0.02

20.002 to 0.01
0.006

0.01
4,835

4,836
0.13
20.01 to 0.08

0.003
0.05
4,843
HDL-cholesterol (mmol/L)

PLOS ONE | www.plosone.org

0.03
4,844
Log transformed triglycerides (mmol/L)

0.02 to 0.08

,0.001
0.34 to 0.65
0.49
4,843
0.01
1.15
4,849
Diastolic blood pressure (mmHg)

0.23 to 2.07

,0.001

p value
95% CI

0.55 to 1.12
0.84

1b
n

4,847
0.26

p value
95% CI

20.74 to 2.74
1.00

1b
n

4,853
Systolic blood pressure (mmHg)

{Observational Multivariable regression
Mendelian randomization Instrumental variable analysis

Table 2. Mendelian randomization estimates, obtained from instrumental variable analysis using 2SLS and probit regression, and multivariable linear and probit regression
estimates of the association of alcohol use (1 unit) with CVD risk factors and morbidity.
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6
4,572

Self-reported IHD

1.07

0.95

0.82 to 1.39

0.74 to 1.21

95% CI

20.01 to 0.02

20.01 to 0.09

0.02 to 0.08

20.008 to 0.08

0.50 to 2.24

20.50 to 2.77

95% CI

"

1

adjusted for age, education, physical activity, smoking and use of appropriate medication (CVD risk factors only).
per alcohol unit change (10 grams ethanol/day).
Odds ratio is approximated by the antilogarithm of (1.66 probit coefficient).
doi:10.1371/journal.pone.0068054.t003

{

4,572

Odds ratio

n

Self-reported CVD

0.005

4,544

Log transformed fasting glucose (mmol/L)

0.04

4,547

0.05

0.03

LDL-cholesterol (mmol/L)

4,551

Log transformed triglycerides (mmol/L)

1.37

4,550

4,557

Diastolic blood pressure (mmHg)

1b
1.14

HDL-cholesterol (mmol/L)

4,559

Systolic blood pressure (mmHg)

n

Mendelian randomization Instrumental variable analysis
p value

0.63

0.68

p value

0.54

0.14

0.001

0.11

0.002

0.17

4,569

4,569

n

4,537

4,539

4,542

4,543

4,551

4,553

n

0.99

1.00

Odds ratio

0.005

0.01

0.01

0.006

0.48

0.84

1b

0.94 to 1.05

0.95 to 1.04

95% CI

0.002 to 0.007

0.00 to 0.02

0.008 to 0.02

20.001 to 0.01

0.33 to 0.64

0.55 to 1.12

95% CI

{Observational Multivariable regression

0.77

0.87

p value

,0.001

0.04

,0.001

0.11

,0.001

,0.001

p value

Table 3. Mendelian randomization estimates, obtained from instrumental variable analysis using 2SLS and probit regression, and multivariable linear and probit regression
estimates of the association of alcohol use (1 unit) with CVD risk factors and morbidity, excluding former users.
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4,577

0.80

0.62 to 1.05

0.10

CVD and its risk factors were most evident in the younger men
(Table 5).
Despite these limitations, our findings for CVD risk factors are
similar in direction and interpretation to those from nonobservational studies. The Mendelian randomization estimates of
the effect of one alcohol unit (10 g of ethanol per day) on diastolic
blood pressure and HDL-cholesterol were higher than those
reported from RCTs [10,11]. Most RCTs of alcohol use concern
free-living people in western populations. Any lapse in compliance
would underestimate the effect of alcohol. Moreover, the effect of
reducing from high alcohol consumption, as often examined [9],
may not be the same as increasing from negligible or low alcohol
consumption. Prior lifelong alcohol use may also compromise
these inevitably short trials [10,11]. Our estimates also had wide
confidence intervals, which included estimates from intervention
studies [9,11]. However, it is possible that the differences in the
estimates between our study and RCTs could be due to differences
in the participants studied in these designs or violations of the
instrumental variable assumptions [33], although we have
established the credibility of ALDH2 as an instrumental variable
for alcohol use [25], or possible over-estimation of the magnitude,
but not direction, of the Mendelian randomization estimate from
instrumental variable analysis [34]. Instrumental variable analyses
estimates generated as the association of genetic variant with the
outcome divided by the association of genetic variant with the
exposure may be inflated by reverse causality if the outcome affects
the exposure in such a way as to reduce the association of the
genetic variant with the exposure.
Our results suggest that moderate alcohol use has no effect on
CVD, IHD or fasting glucose, which is different from western
observational studies where moderate alcohol use is associated
with lower morbidity or mortality from CVD and diabetes [1–3].
However, these findings from western settings have not always
been replicated in non-western settings [6–8]. Such discrepancies
might indicate that any observed protective effects in western
contexts are due to confounding rather than to the biological
properties of alcohol although the null results, in particular for
CVD and IHD, had limited statistical power and do not preclude
small protective effects. Alternatively, given that moderate alcohol
use has both healthy and unhealthy effects on CVD risk factors the
net effect may depend on the CVD risk profile in any given
population [35]. Higher HDL-cholesterol is thought to underlie
the cardioprotection of moderate alcohol use [36]. However, the
causal role of HDL-cholesterol has been challenged by a recent
meta regression analysis of RCTs of lipid modifying drugs and by
two Mendelian randomization studies where genetically higher
HDL-cholesterol had little effect on IHD [37–39]. The mechanistic pathway by which alcohol confers cardioprotection may
need to be extended beyond HDL-cholesterol. Lower respiratory
mortality has been observed with moderate alcohol use, with
corresponding implications for CVD morbidity and mortality
[40]. Respiratory benefits of alcohol may occur via antiinflammatory pathways [41]. Alternatively, alcohol reduces
testosterone [42], which would be expected to reduce inflammation [43], giving a possible pathway. However, to our knowledge
whether alcohol operates via these pathways has not been
comprehensively assessed.
From a public health perspective, our study using a potentially
less biased design, suggests no benefit of moderate alcohol use on
CVD, IHD or some CVD risk factors including fasting glucose.
On the other hand, our null associations of moderate alcohol use
with IHD and CVD might suggest a non-causal role of moderate
alcohol use, but had limited statistical power. Larger studies are
needed to confirm these findings.

"

1

{

adjusted for age, education, physical activity, smoking and use of appropriate medication (CVD risk factors only).
per alcohol unit change (10 grams ethanol/day).
Odds ratio is approximated by the antilogarithm of (1.66 probit coefficient).
doi:10.1371/journal.pone.0068054.t004

0.38
0.53 to 5.23
1.67
4,580
Self-reported IHD

p value

0.14
0.67 to 1.06

95% CI
Odds ratio

0.84
4,577

n
p value

0.92
0.32 to 2.81

95% CI
Odds ratio

0.94

n

4,580
Self-reported CVD

0.02
0.002 to 0.02
0.01
4,545
0.55
0.02
4,552
Log transformed fasting glucose (mmol/L)

0.09
4,553

20.05 to 0.09

,0.001

0.61
20.05 to 0.03
20.01
4,546
0.45

0.96

LDL-cholesterol (mmol/L)

20.14 to 0.31

0.03 to 0.08

20.03 to 0.03
0.00

0.05
4,551

4,552
0.34
20.10 to 0.28

0.01
0.16
4,558
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0.09
4,559
Log transformed triglycerides (mmol/L)

HDL-cholesterol (mmol/L)

0.03 to 0.29

,0.001
1.08 to 2.39
1.74
4,558
0.06
3.73
4,564
Diastolic blood pressure (mmHg)

20.11 to 7.57

,0.001

p value
95% CI

1.07 to 3.50
2.29

1b
n

4,562
0.73

p value
95% CI

26.01 to 8.61
1.30

1b
n

4,568
Systolic blood pressure (mmHg)

{Observational Multivariable regression
Mendelian randomization Instrumental variable analysis

Table 4. Mendelian randomization estimates, obtained from instrumental variable analysis using 2SLS and probit regression, and multivariable linear and probit regression
estimates of the association of alcohol use (1 unit) with CVD risk factors and morbidity, excluding heavy users.
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2,421
2,424

Systolic blood pressure (mmHg)

Diastolic blood pressure (mmHg)

Diastolic blood pressure (mmHg)

Age .63.5

Age!63.5

Age .63.5

n
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Self-reported CVD

Self-reported IHD

Self-reported IHD

Age!63.5

Age .63.5

2,431

2,436

2,431

0.99

1.38

0.89

1.26

0.71 to 1.39

0.93 to 2.05

0.66 to 1.20

0.84 to 1.87

95% CI

"Odds ratio

2,436

20.01 to 0.03

0.01

20.02 to 0.03

20.04 to 0.10

20.06 to 0.10

20.01 to 0.07

0.02 to 0.11

20.03 to 0.08

20.03 to 0.11

21.09 to 1.21

0.82 to 3.87

22.92 to 1.79

n

0.009

0.03

0.02

0.03

0.07

0.02

0.04

0.06

2.34

20.57

95% CI
0.47 to 5.69

2,416

2,421

2,416

2,423

1b
3.08

"

1

adjusted for age (continuous), education, physical activity, smoking and use of appropriate medication (CVD risk factors only).
per alcohol unit change (10 grams ethanol/day).
Odds ratio is approximated by the antilogarithm of (1.66 probit coefficient).
doi:10.1371/journal.pone.0068054.t005

{

Self-reported CVD

Age .63.5

Log transformed fasting glucose (mmol/L)

Age .63.5

Age!63.5

Log transformed fasting glucose (mmol/L)

Age!63.5

2,422

LDL-cholesterol (mmol/L)

LDL-cholesterol (mmol/L)

Age!63.5

HDL-cholesterol (mmol/L)

Age .63.5

Age .63.5

2,420

HDL-cholesterol (mmol/L)

Age!63.5

2,420

Log transformed triglycerides (mmol/L)

Log transformed triglycerides (mmol/L)

Age!63.5

Age .63.5

2,428

2,423

2,430

CVD risk factor or morbidity

Systolic blood pressure (mmHg)

Age group

Age!63.5

0.97

0.11

0.43

0.26

p value

0.31

0.46

0.40

0.60

0.16

0.005

0.39

0.27

0.92

0.003

0.64

0.02

p value

Mendelian randomization Instrumental variable analysis

2,428

2,436

2,428

2,436

n

2,410

2,420

2,410

2,420

2,414

2,421

2,414

2,422

2,417

2,426

2,419

2,428

n

0.99

1.00

1.00

0.98

Odds ratio

0.005

0.005

0.02

0.004

0.01

0.02

0.005

0.007

0.52

0.46

0.84

0.86

1b

0.92 to 1.06

0.92 to 1.08

0.94 to 1.06

0.91 to 1.06

95% CI

0.001 to 0.008

0.001 to 0.008

0.002 to 0.03

20.009 to 0.02

0.002 to 0.02

0.01 to 0.03

20.006 to 0.02

20.004 to 0.02

0.31 to 0.73

0.24 to 0.68

0.42 to 1.27

0.48 to 1.24

95% CI

{Observational Multivariable regression

0.69

0.96

1.00

0.65

p value

0.009

0.01

0.03

0.55

0.02

,0.001

0.40

0.22

,0.001

,0.001

,0.001

,0.001

p value

Table 5. Mendelian randomization estimates, obtained from instrumental variable analysis using 2SLS and probit regression, and multivariable linear and probit regression
estimates of the association of alcohol use (1 unit) with CVD risk factors and morbidity stratified by median age.
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